retatrutide phase 3 trial dosing schedule Reta clinical data & — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in trials for metabolic health — targeting GLP-1, GIP Retatrutide Dosing Schedule: Week-by-Week Protocol

GLP-1 medications are well-studied fat-loss tools, but they dont automatically lead to a stronger physique

Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, et al

Betul Hatipoglu, director of the Center for Diabetes, Obesity and Metabolism at Case Western Reserve University and of the Diabetes and Obesity Center at University Hospitals Cleveland Medical Center, says microdosing Ozempic, Zepbound or another GLP-1 drug might mean: Taking a lower dose than what was prescribed or studied in clinical trials Taking a half-dose every few days instead of a full dose once weekly Taking a full dose less often, such as every 10 or 14 days instead of every seven While these approaches are often grouped together online under the umbrella of "microdosing," they're not exactly the same thing

The abdomen typically offers the fastest absorption, followed by the thigh, then the arm

These findings come from comparisons across different studies, not from direct head-to-head trials

However, starting in July 2026, a new program called the BALANCE Model may give eligible Medicare Part D beneficiaries access to certain GLP-1 weight loss medications for a $50 copay